“The curing behavior of the dicyanate ester of bisphenol-A (DCBA) modified with poly(hydroxy ether of bisphenol-A) (phenoxy) is studied by differential scanning calorimetry in dynamic and isothermal tests at temperatures between 120 and 240 degrees
C. The addition of phenoxy to DCBA produces an increase in the reaction rate and a decrease in the temperature of maximum reaction rate for the uncatalyzed resin, and also for the system catalyzed with copper (II) acetyl acetonate/nonylphenol. The exothermic heat of curing for the mixtures is also dependent on the phenoxy content. These facts evidence a catalytic effect of phenoxy on the curing of the cyanate ester resin, even though an autocatalytic behavior is observed for all uncatalyzed DCBA/phenoxy mixtures. A simplified mechanistic
kinetic model is used to calculate the kinetic LDN-193189 chemical structure parameters. For the uncatalyzed systems, a decrease in the kinetic constant for the initiation reactions, and an increase in the propagation constant are measured when the cyanate content increases. The thermal activation energy for the initiation reaction of the catalyzed systems SN-38 chemical structure is lower than that of the uncatalyzed ones, and it depends on the weight fraction of cyanate in the mixture. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 118: 2869-2880, 2010″
“Smart gel periodontal drug delivery systems (SGPDDS) containing gellan gum (0.1-0.8% w/v), lutrol F127 (14, 16, and 18% w/v), and ornidazole (1% w/v) were CFTRinh-172 manufacturer designed for the treatment of periodontal diseases. Each formulation was characterized in terms of in vitro gelling capacity, viscosity, rheology, content uniformity, in vitro drug release, and syringeability. In vitro gelation time and the nature of the gel formed in simulated saliva for prepared formulations showed polymeric concentration dependency. Drug release data from all formulations was fitted to different kinetic models and the Korsemeyer-Peppas model was the best fit model. Drug release was significantly decreased as the concentration of each polymer component was increased. Increasing the concentration
of each polymeric component significantly increased viscosity, syringeability, and time for 50%, 70%, and 90% drug release. In conclusion, the formulations described offer a wide range of physical and drug release characteristics. The formulation containing 0.8% w/v of gellan gum and 16% w/v of lutrol F127 exhibited superior physical characteristics.”
“Insulin resistance is a major factor in the pathogenesis of type 2 diabetes and underpins the strong association between obesity and diabetes. Paradoxically, the metabolic consequences of having ‘too much’ fat (obesity) are remarkably similar to those of having ‘too little’ fat (lipodystrophy): a finding that has generated considerable interest in a rare disease.